Aytu BioScience

2 Followers

About

Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Our evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As we continue on this trajectory, we’re building a complimentary therapeutic development pipel...

Jarrett Disbrow
Executive Vice President, Corporate Development
Matthew V. Phillips
Executive Vice President, National Accounts
Greg Pyszczymuka
Executive Vice President, Commercial Operations
Richard Eisenstadt
Chief Financial Officer
Nathaniel Massari
Executive Vice President, Rare Disease Operations
Russ Mcmahen
Senior Vice President of Research & Development
Suzane Kennedy
Vice President of Regulatory Affairs and Quality Assurance
Margaret Cabano
Vice President of Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.